Diagnostics News and Research

RSS

Princeton professor receives Agilent Thought Leader Award to research on cellular metabolism activity

Agilent Technologies Inc. today announced that Joshua Rabinowitz, M.D., Ph.D., professor at Princeton University's Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, has received an Agilent Thought Leader Award to support his work on quantitative analysis of cellular metabolism.

18 Apr 2014

SCRA Technology Ventures announces sale of Selah Genomics to EKF Diagnostics

SCRA Technology Ventures today announced that portfolio company Selah Genomics was sold to EKF Diagnostics, a publically-traded UK-based diagnostics firm.

From EKF Diagnostics 17 Apr 2014

OPKO Health enters into definitive agreement to acquire Inspiro Medical

OPKO Health, Inc. has entered into a definitive agreement to acquire Inspiro Medical Ltd., an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. Inspiro's Inspiromatic is a "smart" easy-to-use dry powder inhaler with several advantages over existing devices.

17 Apr 2014

Targeted Medical Pharma signs agreement with Lebanon based company, ATL

Targeted Medical Pharma, today announced the completion of an agreement between Analytical Testing Laboratories (ATL), a Lebanon based company that specializes in drug testing services and inborn errors of metabolism, for the exclusive distribution of the company's amino acid based products to physicians and pharmacies throughout the Middle East.

17 Apr 2014

Findings offer new paths towards improved fertility treatments and development of new contraceptives

Researchers at the Wellcome Trust Sanger Institute have discovered interacting proteins on the surface of the sperm and the egg essential to begin mammalian life. These proteins, which allow the sperm and egg to recognize one another, offer new paths towards improved fertility treatments and the development of new contraceptives.

17 Apr 2014

EKF Diagnostics' new handheld Lactate Scout+ device ideal for checking sports medical health

Since Lactate Scout+ analyzer launch incorporating hematocrit compensation, EKF, is seeing an increasing interest from users in both sports and medical science.

From EKF Diagnostics 17 Apr 2014

Top performing oncology drugs at risk of losing patent rights by 2022

After a period of relative stability, a glut of patent expiries is just five years away for the oncology market, according to pharmaceutical analyst Datamonitor Healthcare.

17 Apr 2014

Iconic Therapeutics completes $20 million Series B-1 equity financing

Iconic Therapeutics, Inc., a biotechnology company focused on developing therapeutics for serious eye disorders, announced today that it has successfully completed a $20 million Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures.

16 Apr 2014

Parabon launches Compute Against Alzheimer's Disease research initiative

Parabon Computation announced today the launch of the Compute Against Alzheimer's Disease (CAAD) research initiative, which will accelerate investigations into the causes and risks of Alzheimer's Disease (AD) through the application of large-scale computational capacity donated by concerned citizens and organizations.

16 Apr 2014

Hooper Holmes enters into Strategic Alliance Agreement with Clinical Reference Laboratory

Hooper Holmes and Clinical Reference Laboratory, Inc. today announced that they have entered into a Strategic Alliance Agreement under which CRL will become Hooper Holmes' exclusive provider of laboratory testing services and Hooper Holmes will become a member of CRL's preferred provider network for wellness programs.

16 Apr 2014

Researchers develop more accurate tool for diagnosing even mild cases of asthma

Using just a single drop of blood, a team of University of Wisconsin-Madison researchers has developed a faster, cheaper and more accurate tool for diagnosing even mild cases of asthma.

16 Apr 2014

Measurement of calcium in coronary arteries can predict heart disease risk

With growing evidence that a measurement of the buildup of calcium in coronary arteries can predict heart disease risk, Los Angeles Biomedical Research Institute (LA BioMed) researchers found that the process of "calcium scoring" was also accurate in predicting the chances of dying of heart disease among adults with little or no known risk of heart disease.

16 Apr 2014

EventusDx completes $2.72M financing to support development, commercialization of Octava breast cancer tests

Eventus Diagnostics, Inc. today announced completion of a $2.72 million financing. The financing was led by a new family office private investor, and existing investors also participated. Proceeds of the financing will mostly be used to support the continued development and commercialization of the company's Octava breast cancer tests.

15 Apr 2014

Henry Schein launches new iPad online ordering application to help veterinary practitioners

Henry Schein Animal Health, the leading companion animal health distributor in the United States, and the U.S. animal health business of Henry Schein, Inc., announced today that it has launched a new iPad® online ordering application to help veterinary practitioners manage their product purchases.

15 Apr 2014

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.

15 Apr 2014

Genetic evidence confirms role of group of virus-fighting genes in cancer development

Researchers have found a major piece of genetic evidence that confirms the role of a group of virus-fighting genes in cancer development.

15 Apr 2014

ICB International develops tracer for imaging alpha-synuclein in Parkinson's disease

On March 4, 2014, ICB International, Inc., ("ICBI"), announced the development of a tracer for imaging alpha-synuclein (a-Syn) in Parkinson's-like mice at the Keystone Symposium for Parkinson disease (PD) in Keystone,Colorado.

11 Apr 2014

Nexstim joins 2014 Red Herring mark of distinction

Red Herring's Top 100 Europe celebrates the exceptional accomplishments of technology companies and their position to grow at an explosive rate. The awards winners were announced today, and Nexstim has proudly been selected in this prestigious group as a Top 100 Europe.

11 Apr 2014

EU-funded project aims to find solution to combat hepatitis C epidemic in Egypt

New ways to differentiate between chronic and self-clearing infections may help towards effective patient management and reduce drug costs. But there are major challenges in implementation.

11 Apr 2014

Abbott completes enrollment of 3 clinical trials to support approval of Absorb Bioresorbable Vascular Scaffold

Abbott (NYSE: ABT) today announced it has completed enrollment of three clinical trials to support approvals of the company's revolutionary Absorb™ Bioresorbable Vascular Scaffold (BVS) in the United States, Japan and China.

10 Apr 2014

Diagnostics News and Research

Princeton professor receives Agilent Thought Leader Award to research on cellular metabolism activity

SCRA Technology Ventures announces sale of Selah Genomics to EKF Diagnostics

OPKO Health enters into definitive agreement to acquire Inspiro Medical

Targeted Medical Pharma signs agreement with Lebanon based company, ATL

Findings offer new paths towards improved fertility treatments and development of new contraceptives

EKF Diagnostics' new handheld Lactate Scout+ device ideal for checking sports medical health

Top performing oncology drugs at risk of losing patent rights by 2022

Iconic Therapeutics completes $20 million Series B-1 equity financing

Parabon launches Compute Against Alzheimer's Disease research initiative

Hooper Holmes enters into Strategic Alliance Agreement with Clinical Reference Laboratory

Researchers develop more accurate tool for diagnosing even mild cases of asthma

Measurement of calcium in coronary arteries can predict heart disease risk

EventusDx completes $2.72M financing to support development, commercialization of Octava breast cancer tests

Henry Schein launches new iPad online ordering application to help veterinary practitioners

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Genetic evidence confirms role of group of virus-fighting genes in cancer development

ICB International develops tracer for imaging alpha-synuclein in Parkinson's disease

Nexstim joins 2014 Red Herring mark of distinction

EU-funded project aims to find solution to combat hepatitis C epidemic in Egypt

Abbott completes enrollment of 3 clinical trials to support approval of Absorb Bioresorbable Vascular Scaffold

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News